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An increasing number of proteins involved in genomeorganization have been implicated in neurodevelopmental disorders, highlighting
the importance of chromatin architecture in the developing CNS. The CCCTC-binding factor (CTCF) is a zinc finger DNAbinding protein
involved in higher-order chromatin organization, and mutations in the human CTCF gene cause an intellectual disability syndrome
associatedwithmicrocephaly. However, information on CTCF function in vivo in the developing brain is lacking. To address this gap, we
conditionally inactivated the Ctcf gene at early stages of mouse brain development. Cre-mediated Ctcf deletion in the telencephalon and
anterior retinaat embryonicday8.5 triggeredupregulationof thep53effectorPUMA(p53upregulatedmodulatorof apoptosis), resulting
in massive apoptosis and profound ablation of telencephalic structures. Inactivation of Ctcf several days later at E11 also resulted in
PUMAupregulation and increased apoptotic cell death, and theCtcf-null forebrainwas hypocellular and disorganized at birth. Although
deletion of bothCtcf andPuma in the embryonic brain efficiently rescuedCtcf-null progenitor cell apoptosis, it failed to improveneonatal
hypocellularity due to decreased proliferative capacity of rescued apical and outer radial glia progenitor cells. Thiswas exacerbated by an
independent effect of CTCF loss that resulted in depletion of the progenitor pool due to premature neurogenesis earlier in development.
Our findings demonstrate that CTCF activities are required for two distinct events in early cortex formation: first, to correctly regulate the
balance between neuroprogenitor cell proliferation and differentiation, and second, for the survival of neuroprogenitor cells, providing new
clues regarding the contributions of CTCF inmicrocephaly/intellectual disability syndromepathologies.
Key words: apoptosis; CTCF; differentiation; mouse model; neurogenesis; Puma
Introduction
CTCF is a multifunctional DNA binding protein that regulates
higher-order chromatin structure to influence transcriptional
regulation, genomic imprinting, X chromosome inactivation,
and chromatin insulation (Holwerda and de Laat, 2013). It binds
to a variety of highly divergent target sequences throughout the
genome using a combination of its 11 zinc finger motifs (Naka-
hashi et al., 2013). CTCF partners with a number of chromatin-
related proteins such as the cohesin complex (Parelho et al., 2008;
Wendt et al., 2008), nucleophosmin, and CTCF itself (Yusufzai
and Felsenfeld, 2004; Yusufzai et al., 2004). These interactions
may allow CTCF sites to contact one another and/or to be teth-
ered to subnuclear domains. CTCF-mediated chromatin interac-
tions detected by Chromatin interaction analysis by paired-end
tag sequencing (ChIA-PET) correlate with 10% of all CTCF
binding sites (CBSs), however, indicating that CTCF likely plays
additional roles within the cell (Handoko et al., 2011).
De novomutations inCTCF have been identified previously in
patients with varying degrees of intellectual disability andmicro-
cephaly (Gregor et al., 2013), highlighting the importance of
chromatin organization for the normal development and func-
tion of the CNS.Whereas CTCF function has been studied exten-
sively in cell culture systems, its function in an in vivo context
remains to be completely resolved (Ohlsson et al., 2010). Ubiq-
uitous deletion of CTCF in the mouse leads to lethality before
embryonic day 3.5 (E3.5), suggesting that it is essential for early
developmental processes (Fedoriw et al., 2004; Heath et al., 2008;
Moore et al., 2012). Conditional deletion ofCtcf in specific tissues
causes either reduced proliferation or apoptotic cell death, de-
pending on the tissue targeted for Cre recombination. For exam-
ple, deletion of Ctcf in thymocytes resulted in increased p21 and
p27 expression and cell cycle arrest, whereas reduced CTCF in
mouse oocytes induced meiotic and mitotic defects and apopto-
tic cell death before the blastocyst stage (Fedoriw et al., 2004;
Heath et al., 2008; Wan et al., 2008). Deletion of Ctcf in the
developing limb bud resulted in massive apoptosis and near-
complete loss of limb structures, accompanied by increased p53
upregulatedmodulator of apoptosis (PUMA), a known activator
of caspase-mediated apoptosis (Nakano and Vousden, 2001; Yu
et al., 2001; Soshnikova et al., 2010). In human cancer cells, CTCF
binds to the Puma gene, and its depletion results in increased
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Puma transcript and rapid apoptosis, indicating that Puma tran-
scription can be directly influenced by the presence or absence of
CTCF (Gomes and Espinosa, 2010a,b).
Given the deleterious effects ofCTCFmutations in the human
CNS, we specifically inactivated Ctcf in the developing mouse
brain. CTCF loss of function using two different Cre driver lines
in mice triggered apoptosis in dividing neuroprogenitor cells
(NPCs) of the forebrain. Despite prevention of apoptosis by
Puma deletion, rescued Ctcf/Puma double-null apical and outer
radial glia (oRG) progenitors exhibited decreased proliferative
capacity. Furthermore, loss of CTCF caused premature neuro-
genesis, resulting in depletion of the progenitor pool and a mi-
crocephaly phenotype at birth. These findings highlight the
complexity of CTCF activities during neurogenesis.
Materials andMethods
Mouse husbandry and genotyping. Mice were exposed to 12 h light/dark
cycles and fed tap water and regular chow ad libitum. The Ctcf loxP mice,
in which loxP sites flank exons 3–12, have been described previously
(Heath et al., 2008).Mice conditionally deficient inCTCFwere generated
by crossingCtcf loxP/ females (C57BL/6 background) with heterozygous
Foxg1Cre knock-in male mice (129/sv background) or with NestinCre
heterozygous male mice (C57BL/6 background; He´bert andMcConnell,
2000; Be´rube´ et al., 2005). To account for decreased Foxg1 expression due
to knock-in of the Cre recombinase gene, Cremales were used as con-
trols (Ctcf/Foxg1-cre/) unless stated otherwise. Using theNestinCre
driver line, Ctcf loxP/loxP mice were crossed with Ctcf loxP/;Nestin mice
to generate Ctcf lox/P/loxP or Ctcf loxP/ (controls) and Ctcf loxP/loxP;Nestin
(CtcfNes-cre). Puma/ (Bbc3tm1Ast) mice were obtained from The Jack-
son Laboratory (stock #011067; Villunger et al., 2003). DNA from tail
biopsies of newborn pups or yolk sac from embryos was genotyped by
PCR. Primer sequences are provided in Table 1.
Immunostaining and histology. For immunofluorescence staining,
cryosections were incubated with the primary antibody overnight at 4°C,
washed in PBS/0.3% Triton-X 100, and incubated with the secondary
antibody for 1 h. Sections were counterstained with DAPI (Sigma-
Aldrich) andmounted in SlowFade Gold (Invitrogen). Primary antibod-
ies used were as follows: rabbit anti-CTCF (1:400; Cell Signaling
Technology), rabbit anti-cleaved caspase 3 (AC3; Asp175; 1:400; Cell
Signaling Technology), mouse anti-BrdU (1:50; BD Biosciences), rabbit
anti-PUMA(1:200; Cell SignalingTechnology), rabbit anti-TBR2 (1:200;
Abcam), goat anti-SOX2 (1:400; Santa Cruz Biotechnology), goat anti-
PAX6 (1:200; Santa Cruz Biotechnology), rabbit anti-SOX2 (1:100; Mil-
lipore Bioscience Research Reagents), rabbit anti-Ki67 (1:200; Abcam),
rabbit anti-TBR1 (1:200; Abcam), mouse anti-SATB2 (1:200; Abcam),
and rabbit anti-CTIP2 (1:200; Abcam). Secondary antibodies used were
as follows: goat-anti-rabbit Alexa 594 (1:800; Invitrogen), goat-anti-
mouse Alexa 488 (1:800; Invitrogen), donkey-anti-sheep Alexa 594 (1:
800; Invitrogen), and donkey-anti-mouse Alexa 488 (1:800; Invitrogen).
Sections were subjected to antigen retrieval (incubated in 0.1mM sodium
citrate, pH 6.0, heated to 95°C and microwaved on low for 10 min)
before overnight incubation (for BrdU, SOX2, PAX6, TBR2, STAB2,
TBR1, and CTIP2). Terminal deoxynucleotidyl nick end labeling
(TUNEL) was performed according to the manufacturer’s instructions
(Roche). For histological studies, slides were stained with hematoxylin
and eosin (H&E).
BrdU labeling. Pregnant mice were injected intraperitoneally with cell
proliferation labeling reagent [10 mM bromodeoxyuridine (BrdU) and 1
mM fluorodeoxyuridine (FdU) in H2O] at 1ml/100 g body weight, or 0.3
mg/g body weight (GE Healthcare Life Sciences). Animals were killed
after 1 h by CO2 asphyxiation, and the embryos were recovered in ice-
cold PBS, pH 7.4, and were fixed in 4% paraformaldehyde. Tissue was
equilibrated in 30% sucrose/PBS and frozen in OCT (Tissue Tek). For
cell cycle exit analysis, pregnant femalemice (E13) were injected with cell
proliferation labeling reagent at 1 ml/100 g body weight (GE Healthcare
Life Sciences), and embryos were collected and processed for immuno-
fluorescence analysis 24 h later. Before immunofluorescence analysis,
cryosections (8m)were treated with 2NHCl to denature theDNA, and
neutralized with 0.1 M Na2B4O7, pH 8.5.
Primary NPC cultures and manipulation. Cortical progenitor cultures
were prepared as described previously (Slack et al., 1998; Gloster et al.,
1999; Watson et al., 2013) using cortices dissected from E12.5 embryos.
Cells were seeded onpolyornithine-coated (Sigma-Aldrich) plastic plates
or glass coverslips. Cells were fixed in 4% paraformaldehyde for 10 min,
washed in PBS, andprocessed for immunofluorescence. Cell viabilitywas
measured using the trypan blue dye exclusion method. Cell counts were
determined with a hemacytometer.
Western blot analysis. Nuclear protein was extracted from the E16.5
telencephalon using a standard extraction kit (Thermo Scientific) and
quantified using the Bradford assay. Protein (20 g) was resolved on a
6% SDS-polyacrylamide gel and transferred onto a nitrocellulose mem-
brane (Bio-Rad). Themembranewas probedwith rabbit anti-p53 (1:500;
Santa Cruz Biotechnology) and rabbit anti-inner centromere protein
(INCENP) (1:10000; Sigma Aldrich) antibodies followed by the appro-
priate horseradish peroxidase-conjugated secondary antibodies (1:4000;
GE Healthcare Life Sciences). The membrane was incubated in ECL be-
fore exposure to x-ray film. Densitometry analysis was performed using
ImageJ software (version 1.47).
Real-time PCR. Total RNA was isolated using the RNeasy Mini kit
(Qiagen). First-strand cDNA was synthesized from 1 g of total RNA
using the SuperScriptTM II Reverse Transcriptase kit (Invitrogen) with
deoxyribonucleotide triphosphates (dNTPs) (1 mM final concentration;
GE Healthcare), porcine RNAguard (GE Healthcare), and 0.3 g ran-
dom primers (GE Healthcare). Amplification was performed using a
Chromo-4 Continuous Fluorescence Detector (Bio-Rad) in the presence of
iQSYBRGreen supermix (Bio-Rad) and recordedusingOpticonMonitor 3
software (Bio-Rad). Results were normalized to-actin expression, and rel-
ativegeneexpression levelswerecalculatedusingGeneXsoftware (Bio-Rad).
Samples were amplified as follows: 95°C for 10 s, annealed for 20 s, 72°C for
30 s. After amplification, a melting curve was generated, and samples were
resolved on a 1.5% agarose gel (75 V for 1 h) to verify amplicon purity.
Primer oligomers were designed using Primer3 software (http://bioinfo.ut.
ee/primer3-0.4.0/primer3/) andwere obtained from IntegratedDNATech-
nologies. Sequences are provided in Table 1.
Chromatin immunoprecipitation. Chromatin immunoprecipitation
(ChIP) experiments were performed as described previously (Kernohan
et al., 2010). Briefly, mouse forebrain tissue was dissected and processed
to single-cell suspension. Cells were cross-linked in 1% formaldehyde,
lysed in SDS buffer and sonicated. Immunoprecipitation was performed
with a rabbit anti-CTCF antibody (Cell Signaling Technology) and a
rabbit anti-p53 antibody (Santa Cruz Biotechnology). Input samples
represent 1/25 of total chromatin input. ChIP products were amplified in
duplicate with iQ SYBR Green Master Mix (Bio-Rad) on a Chromo-4
thermocycler under the following conditions: 95°C for 5 min, followed
by 35 cycles of 95°C for 10 s, 55°C for 20 s, 72°C for 30 s, and a final
Table 1. Primer sequences used for genotyping, gene expression, and qChIP
analyses
Primer Name Forward sequence (5-3) Reverse sequence (5-3)
Ctcf CTAGGAGTGTAGTTCAGTGAGGCC GCTCTAAAGAAGGTTGTGAGTTC
NestinCre TGACCAGAGTCATCCTTAGCG AATGCTTCTGTCCGTTTGCC
Sry GCAGGTGGAAAAGCCTTACA AAGCTTTGCTGGTTTTTGGA
Puma genotyping WT AGGCTGTCCCTGCGGTCATCC GGACTGTCGCGGGCTAGACCCTCTA
Puma genotyping KO AGGCTGTCCCTGCGGTCATCC ACCGCGGGCTCCGAGTAGC
Ctcf expression CGATATGCTCTCATCCAGCA TCCCACACTTGGAACAGACA
Puma expression CGTGTGGAGGAGGAGGAGT GGAGGAGTCCCATGAAGAGA
-actin expression CTGTCGAGTCGCGTCCACCC ACATGCCGGAGCCGTTGTCG
5 5 kb Puma CBS ACCCTCGTGTTTGGAGTGAC CTCCTGCCTTGTGCCTAAAG
Puma CBS1 GCTCCTCCCAGGTCTCACTA CAGCTTTCATCACTGGGACT
Puma CBS2 AGGAATGGATCTGCTGGATG GTTGCTGACTCACCGGCTAT
3 5 kb Puma CBS GAGCCCCTGCCTAGTAGGAT TAGTCCCTGTGTGTGCTTGC
5 1 kb p53BS AAAAATGGGCTTGGAGAGC CCACCACTGTCCAGCTTGTT
Puma p53BS CTGTCCCCACGCTGC GCTTGCTTGCTGGTGTCG
3 1 kb p53BS AGCCAGGGCTACACAGAGAA CTGAGCCATCTCTCCAGTCC
KO, Knock-out; WT, wild type.
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melting curve generated from55°C to 95°C in increments of 1°Cper plate
read. Fold change and percent input formulas were adapted from (Muk-
hopadhyay et al., 2008) as follows: percent input 100 * [2(CtInput
CtInput)  (CtInput  CtAb)]/25. Error bars represent the SEM.
Primer sequences are provided in Table 1.
Microscopy. Images were captured with a digital camera (ORCA-ER;
Hamamatsu) using an inverted microscope (DMI 6000b; Leica). Open-
lab imaging software (PerkinElmer) was used for manual image capture,
and processing was performed using Volocity software (PerkinElmer).
For quantification of AC3 cells per area, AC3 cells were counted in a
defined area in at least six serial cortical cryosections, and the ratio of
AC3 cells to area (squaremillimeters) was calculated. For BrdU, SOX2,
TBR2, BrdU/Ki67, TBR1, SATB2, and CTIP2 quantification, at least two
serial cortical cryosections were assessed for positive cells within the in-
dicated regions per embryo. DAPI morphology was used to bin cortex
into the ventricular/subventricular zone (VZ/SVZ), intermediate zone
(IZ), and cortical plate (CP).
Statistical analyses. Statistical analysis was performed using GraphPad
Prism software (GraphPad Software; version 4.02), and all results are
expressed as the mean SEM. Unless indicated otherwise, p values were
generated using Student’s t test (unpaired, two-tailed) to compare be-
tween two independent data sets. Genotype ratios (Figs. 1A, 2A) were
compared using a  2 test. To compare cell viability data (see Fig. 4E), a
one-way ANOVA was used with Dunnett’s multiple comparison post-
test to compare the cell viability of each genotype (CtcfNes-cre, CtcfNes-cre;
Puma/, and Puma/) to control.
Study approval. All procedures involving animals were conducted in
accordance with the regulations of the Animals for Research Act of the
Province of Ontario and approved by the University of Western Ontario
Animal Care and Use Committee.
Results
CtcfFoxg1-cremice exhibit widespread apoptosis and profound
loss of telencephalic and anterior retinal tissue
To study the function of CTCF in the embryonic brain, Ctcf
floxed mice were intercrossed with the previously characterized
Foxg1Cremice (He´bert andMcConnell, 2000; Be´rube´ et al., 2005;
Heath et al., 2008). Foxg1 expression is first detected between E8
and E9 in the telencephalic neuroepithelium, the basal ganglia,
the olfactory bulbs, and the anterior retina (Dou et al., 1999).
Foxg1-cre Ctcf loxP/loxP progeny resulting from this cross are Ctcf
Figure1. Foxg1Cre-mediateddeletionof Ctcf results in amassive increase in apoptosis.A, Table of genotypes obtainedduring the embryonic andpostnatal periods. Ratios at each timepointwere
analyzed using a 2 test. Het, Ctcf flox/WT;Foxg1-cre/. B, Dark-field images of control and Ctcf Foxg1-cre embryos at E13.5. (Please note limbs were taken for genotyping). C, H&E staining of E13.5
sagittal cryosections demonstrates complete loss of cortex (Ctx), hippocampal hem (H), basal ganglia (BG), lens (L), and anterior retina (AR), but not the posterior retina (PR), in Ctcf Foxg1-cre embryos.
D, Dark-field images of control and Ctcf Foxg1-cre embryos at E11.5. The dashed circle outlines the telencephalon, which is visibly reduced in size in the Ctcf Foxg1-cre embryos compared to littermate
controls. E, Immunodetection of CTCF (red) in E11.5 sagittal cryosections confirms specific loss of CTCF expression in the forebrain neuroepitheliumof Ctcf Foxg1-cre embryos. F, Pregnant femaleswere
subjected to a 1 h BrdU pulse before being killed. Immunodetection of BrdU in E11.5 control and Ctcf Foxg1-cre cortical neuroepithelium is shown. G, BrdU cells were counted and expressed as a
percentage of the total number of DAPI cells (n 3).H, Immunodetection of activated caspase-3 (red) in control and Ctcf Foxg1-cre cortical neuroepithelium at E11.5. I, AC3 cells were counted
and expressed as a percentage of the total number of DAPI cells (n 3). J, TUNEL (green) detection in E11.5 control and Ctcf Foxg1-cre cortical neuroepithelium. Error bars represent the SEM.
Original magnification: C, 25	; E, 50	; F, H, J, 200	. Scale bars: C, top, 1 mm; bottom, 400m; E, 200m; F, H, 50m; J, 100m.
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null in the anterior retina and forebrain, and will be referred to as
CtcfFoxg1-cre throughout this text.
We failed to recover liveCtcfFoxg1-cre pups at birth (Fig. 1A). At
E13.5, the size of telencephalic and retinal structures was greatly
diminished in mutant embryos (Fig. 1B,C). At E11.5, the telen-
cephalon of mutant embryos was already noticeably smaller
compared to littermate-matched controls (Fig. 1D, hatched cir-
cle). CTCF immunostaining demonstrated nuclear expression of
the protein throughout the forebrain in control tissue and its
absence in mutant embryos (Fig. 1E). To determine the underly-
ing cause of cell loss, we measured levels of proliferation and cell
death in E11.5 CtcfFoxg1-cre and control embryos. Acute (1 h)
BrdU labeling of control and CtcfFoxg1-cre embryos revealed that
the percentage of cells in S phase does not vary significantly be-
tween mutant and control forebrain tissue (Fig. 1F,G). To mea-
sure apoptosis, we stained sections with an antibody against
activated caspase-3 as a marker of cell death (Fig. 1H). Quantifi-
cation of the results revealed a large increase in the proportion of
cells undergoing apoptotic cell death in CtcfFoxg1-cre embryos
compared to littermate-matched controls (Fig. 1I). TUNEL also
showed increased apoptosis in CtcfFoxg1-cre embryos compared to
control (Fig. 1J). Since we already observed profound cell loss by
E11.5, we wanted to analyze whether a similar mechanism was
occurring earlier in this system. We observed increased AC3 im-
munostaining in CtcfFoxg1-cre forebrain cryosections at E10.5,
confirming that cell death occurs at this earlier time point (data
not shown). We conclude that deletion of Ctcf in the mouse
forebrain at approximately E8.5 causes extensive apoptosis re-
sulting in profound loss of telencephalic and anterior retinal tis-
sue by E13.5.
NestinCre-driven inactivation of Ctcf decreases cell survival
To determine the outcome of Ctcf deletion at a later embryonic
time point in the telencephalon, we mated Ctcf flox/floxmice to the
previously characterized NestinCre transgenic mice (Be´rube´ et
al., 2005; Heath et al. 2008). The resulting mutant is hereafter
referred to as CtcfNes-cre for simplicity. Cre is expressed after pre-
plate formation in this system, resulting in specific deletion of
Ctcf in neural progenitor cells at approximately E11 (Be´rube´ et
al., 2005). We obtained the expected ratio of CtcfNes-cre mice at
birth; however, almost all mutant pups were already dead and
blue in color (Fig. 2A). One live CtcfNes-cre pup was found strug-
gling to breathe, appearedweak, andwas killed.We conclude that
neonatal lethality of CtcfNes-cre mice is likely due to asphyxiation
at birth.
We first established that theCTCFproteinwas lost in the basal
ganglia and many cells of the cortex at E12.5 (Fig. 2B), and ex-
pression was undetectable in the E14CtcfNes-cre cortex, basal gan-
glia, and hippocampal hem (Fig. 2C). To determine whether
NestinCre-mediated deletion of Ctcf also induces apoptosis, we
analyzed CtcfNes-cre forebrain cryosections at E12.5–E15.5 for ev-
idence of AC3. At E12.5, we observed no increase in apoptotic
cells in the mutant telencephalon (Fig. 2D). However, at E14, we
detected an increase in AC3 cells in the CtcfNes-cre cortex, basal
ganglia, and hippocampal hem compared to controls (Fig. 2D).
The increase in caspase activationwas also observed at E15.5 in all
three forebrain regions, with the highest level of AC3 cells in the
basal ganglia (Fig. 2D,E). Increased apoptotic cell death was also
observed in vitro in primary cortical progenitor cultures estab-
lished from E12.5 control and Ctcf-null telencephalon. Levels of
AC3 staining were low in both control and Ctcf-null NPCs after
2 d in vitro (DIV), and we only observed a detectable increase in
staining at 4 DIV (Fig. 2F). Together, the data suggest that when
using the NestinCre driver line of mice, Ctcf deficiency does
trigger the activation of caspase-mediated apoptosis in NPCs,
but the effect is delayed and less severe than that observed in
the Ctcf Foxg1-cre embryos, suggesting that early neuroepithelial
Figure 2. NestinCre-mediated deletion of CTCF results in activation of caspase-mediated
apoptosis. A, Table of genotype ratios obtained during the embryonic period. Ratios at each
time point were analyzed by a  2 test. B, Immunodetection of CTCF in E12.5 control and
Ctcf Nes-cre coronal forebrain sections. C, Immunodetection of CTCF in E14 control and Ctcf Nes-cre
coronal forebrain sections. D, Quantification of AC3 immunostaining in E12.5, E14, and E15.5
forebrain tissue (n 3). AC3 cells were counted and expressed per unit area (square milli-
meter). E, Immunodetection of AC3 in E15.5 control and Ctcf Nes-cre basal ganglia. F, Immuno-
detection of AC3 in control and Ctcf Nes-cre at 4 DIV. Het, Ctcf flox/WT;Nestin-cre; Ctx, cortex; BG,
basal ganglia; H, hippocampal hem. Error bars represent the SEM. Original magnification: B, C,
50	; D, 100	; E, 200	. Scale bars: B, 220m; C, 300m; E, 100m; F, 25m.
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cells are more sensitive to CTCF loss than the neuroprogeni-
tors present slightly later in development.
Increased p53 and PUMA levels in the Ctcf-null telencephalon
Both the Foxg1Cre and NestinCre models of CTCF loss exhibit
increased levels of apoptosis, although the timing of onset differs
between the two mutants. To investigate the molecular mecha-
nism responsible for neuronal cell death due to CTCF loss, we
assessed activation of the p53/PUMA pathway. Using Western
blot analysis, we found that neuronal cell death correlatedwith an
increase in p53 protein levels in the CtcfNes-cre forebrain com-
pared to control, suggesting activation and stabilization of the
protein (Fig. 3A). We next investigated the levels of PUMA,
which has been demonstrated previously to mediate NPC death
downstream of p53 (Jeffers et al., 2003). Moreover, Puma is one
of the most upregulated genes in response to CTCF loss in the
limb bud (Soshnikova et al., 2010). CTCF binding sites in the
Puma gene demarcate an intragenic chromatin boundary that is
abolished upon CTCF knockdown in human cells, resulting in
increased PUMA expression (Gomes and Espinosa, 2010b). To
determine whether PUMA is involved caspase-mediated cell
death in the Ctcf mutant embryos, we examined PUMA protein
levels in theCtcfFoxg1-cre andCtcfNes-cremice. In theE11.5CtcfFoxg1-cre
forebrain, we observed an increase in PUMA immunostaining
compared to littermate controls, corresponding to the high levels
of AC3 staining in these embryos (Fig. 3B). In the CtcfNes-cre em-
bryos, PUMA was increased in the E15.5 basal ganglia, again
correlating with the highest levels of cell death (Fig. 3C). In pri-
mary cultures,Ctcf-null NPCs exhibited increased PUMA immu-
nostaining at 4 DIV when compared to control NPCs obtained
from littermate embryos (Fig. 3D). We also quantified Puma
transcript levels by quantitative reverse-transcriptase PCR and
observed a significant increase in the E16.5 CtcfNes-cre forebrain
compared to controls (Fig. 3E). These observations demonstrate
that increased PUMA transcript and proteins levels occur as a
consequence of CTCF loss in NPCs and correlate with p53 acti-
vation and the onset of caspase-mediated cell death.
PUMA upregulation in the Ctcf-deficient embryonic brain
could result from decreased CTCF occupancy within the Puma
gene body, or because of p53-dependent activation of the gene.
To investigate these possibilities further, we performed quantita-
tive CTCF and p53ChIP using E16.5 telencephalon isolated from
control and CtcfNes-cre embryos (Fig. 3F--H). ChIP analysis con-
firmed CTCF binding sites found downstream of Puma exon 1
(CBS1) and exon 3 (CBS2) at the Puma gene in control tissue,
similar to the binding profile of CTCF in human cancer cells (Fig.
3G; Gomes and Espinosa, 2010a). As expected, CTCF binding
was diminished in the CtcfNes-cre tissue (Fig. 3G). ChIP for p53
demonstrated specific enrichment of the protein at the Puma
promoter in CtcfNes-cre forebrain compared to control in E16.5
tissue (Fig. 3H). Together, loss of CTCF inNPCs causes increased
Puma transcription and protein levels due to increased p53-
dependent transcriptional activation, likely combined with the
loss of CTCF-dependent repression.
Deletion of Puma in a Ctcf-null context rescues cell death, but
does not improve viability or brain defects at birth
To investigate whether increased PUMA levels cause cell death in
the Ctcf-deficient embryonic brain, we introduced a mutant
Puma allele (Bbc3tm1Ast) in the Ctcf loxP and NestinCre mice to
generate mice that lack both Ctcf and Puma expression in the
brain (hereafter referred to as CtcfNes-cre;Puma/). Histological
analysis of E16.5 CtcfNes-cre cryosections showed thinning of the
VZ/SVZ, hypocellularity of the intermediate zone, and a dra-
matic reduction in the size of the hippocampal hem (Fig. 4A).
CtcfNes-cre;Puma/ embryos at E16.5 showed rescue in the VZ/
Figure 3. Loss of CTCF causes p53-dependent transcriptional activation of Puma. A, Western blot analysis of nuclear protein extracts obtained from E16.5 control and Ctcf Nes-cre telencephalon.
Densitometry analysis of blots revealed a 2.3-fold increase in Ctcf Nes-cre p53 levels compared to control. B, C, INCENP was used as a loading control. Immunodetection of PUMA in E11.5 control and
Ctcf Foxg1-cre cortical neuroepithelium (B), E15.5 control and Ctcf Nes-cre forebrain (C), and control and Ctcf-null NPCs (D) at 4 DIV. E, Quantitative real-time PCR analysis of Ctcf and Puma expression in
control and Ctcf Nes-cre E16.5 forebrain using primers spanning Puma exons 3–4 (n 3).-actinwas used as an internal control. F, Schematic representation of themouse Puma gene. PCR products
used to detect sites of CTCF binding (CBS1 and CBS2) and p53 binding (p53BS) are shown. G, Quantitative chromatin immunoprecipitation of CTCF at the Puma gene in E16.5 control and Ctcf Nes-cre
telencephalon tissue (n 3). Primer pairs 5 kb upstreamand downstreamof binding siteswere used as negative controls.H, Quantitative chromatin immunoprecipitation of p53 at the Puma gene
in E16.5 control and Ctcf Nes-cre telencephalon tissue shows increased p53 occupancy at the Puma promoter in the Ctcf Nes-cre telencephalon (n 3). Primer pairs 1 kb upstream and downstream of
the binding site were used as negative controls. Error bars represent SEM. Original magnification: A, C, 200	; B, 100	. Scale bars: B, C, 50m; D, 25m.
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SVZ thickness, as well as hippocampal size (Fig. 4A). We con-
firmed these observations by partitioning the E16.5 cortex into
the CP, IZ, and VZ/SVZ based on cytoarchitecture and quantify-
ing the number of DAPI cells per region (Fig. 4B,C). We ob-
served a restoration in the number of IZ cells and partial
restoration in the number of VZ/SVZ cells in the CtcfNes-cre;
Puma/ compared to CtcfNes-cre cortex (Fig. 4C). There was no
significant difference in the number of CP cells between geno-
types at E16.5 (Fig. 4C).
We performed AC3 immunostaining in E16.5 brain sections
to investigate whether apoptotic cell death was rescued in the
double mutant brain. AC3 cells were elevated in the CtcfNes-cre
cortex, basal ganglia, and hippocampal hem compared to control
(Fig. 4B,D). AC3 cells were largely localized to the ventricular
zone of the neocortex, indicating thatCtcf-null proliferating cells
are more susceptible to caspase-dependent cell death than differ-
entiated cells of the cortical plate. Deletion ofPuma in theCtcfNes-
cremouse was sufficient to abolish apoptotic cell death, indicating
that PUMA mediates increased caspase-dependent cell death in
Ctcf-null neuroprogenitor cells (Fig. 4B,D). Together, these data
indicate a specific decrease in intermediate zone cellularity in the
E16.5 CtcfNes-cre cortex that is fully restored upon inhibition of
cell death. The number of cells in the ven-
tricular/subventricular zone is only par-
tially restored, suggesting that loss of cells
cannot completely be explained by in-
creased cell death.
To further confirm that cell viability is
rescued by deletion of Puma in a Ctcf-null
context, we established primary cortical
progenitor cultures from E12.5 control,
CtcfNes-cre,CtcfNes-cre;Puma/, andPuma/
telencephalon and measured viability via
trypan blue dye exclusion at 2–5 DIV.
Each time point was analyzed by a one-
way ANOVA followed by Dunnett’s mul-
tiple comparisons post-test to determine
which genotypes had a mean percentage
of viability that was significantly different
from control. No difference in viability
was observed at 2 and 3DIV; however, at 4
and 5 DIV, CtcfNes-cre NPCs exhibited a
marked reduction in viability, correlating
with increased levels of AC3 (Fig. 4E).
NPCs obtained from CtcfNes-cre;Puma/
embryos did not show a significant de-
crease in viability at any of the time points
analyzed (Fig. 4E).
Since we observed a rescue in caspase-
mediated cell death in the embryonic
CtcfNes-cre;Puma/ brain, we predicted
that the brain size at birth would also be
recovered and that themicewould survive
into the postnatal period, allowing for
more extended analyses. Surprisingly, we
failed to recover live CtcfNes-cre;Puma/
mice at birth. Histological staining of
postnatal day 0.5 (P0.5) CtcfNes-cre;Pu-
ma/ sections demonstrated severe hy-
pocellularity and disorganization of the
cortical plate and hippocampus, and an
overall similarity to the CtcfNes-cre neona-
tal brain (Fig. 5A). Histological cell counts
confirmed that there are fewer cells in CtcfNes-cre and CtcfNes-cre;
Puma/ cortical plate compared to controls; however, no sig-
nificant difference in cell numberwas detected betweenCtcfNes-cre
and CtcfNes-cre;Puma/ (Fig. 5B). These findings indicate that
although deletion of Puma prevents Ctcf-null cells from under-
going apoptosis, other factors come into play to prevent cortical
size expansion in the double mutant brain.
Ctcf-null apical and oRG progenitors rescued from death by
Puma deletion fail to proliferate
Given that cell death at E16.5 was rescued in the double mutant
embryos but the brain hypocellularity at birth was not, we spec-
ulated that the cells rescued from apoptosis might become ar-
rested in the cell cycle, resulting in decreased proliferation. To test
this hypothesis, we performed acute BrdU labeling at E16.5 and
quantified the proportion of cells in S phase by BrdU immuno-
staining. To compare the cortical distribution and number of
NPCs in S phase, the E16.5 cortexwas partitioned into the CP, IZ,
and VZ/SVZ based on cytoarchitecture (Fig. 6A). The number
of BrdU cells was significantly reduced in the CtcfNes-cre and
CtcfNes-cre;Puma/ intermediate zones and ventricular zone/
subventricular zones compared to control (Fig. 6A,B). Despite
Figure 4. Apoptosis is abolished upon deletion of PUMA in the Ctcf-deficient embryonic brain.A, H&E staining of E16.5 control,
Ctcf Nes-cre, and Ctcf Nes-cre;Puma/ coronal cortical cryosections. Skin and skull cap were not dissected from Ctcf Nes-cre brain. B,
AC3 immunostaining in E16.5 control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma/ neocortex. C, DAPI cells were quantified in 200-m-
wide regions of the control, Ctcf Nes-cre (conditional knock-out), and Ctcf Nes-cre;Puma/ (double knock-out) CP, IZ, and VZ/SVZ
(n 3). D, AC3 cells were quantified per unit area in the cortex (Ctx), basal ganglia (BG), and hippocampal hem (H; n 3). E,
Cell viability of NPC cultures was measured by trypan blue dye exclusion after 2–5 DIV (n 3). Data were analyzed by a one-way
ANOVA followed by Dunnett’s multiple comparisons test to determine which means were significantly different from the control.
No significant difference in cell viability was found at 2 and 3 DIV ( p 0.2122 and 0.2062, respectively); however, viability was
significantly different between Ctcf Nes-cre and control at 3 and 4DIV ( p
 0.01), but not between Ctcf Nes-cre;Puma/ and control
or Puma/ and control ( p 0.05). Error bars represent SEM. Original magnification: A, 100	; C, 50	. Scale bars: A, 200m;
B, 100m.
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substantial rescue in cellularity of the
CtcfNes-cre;Puma/ cortex compared to
CtcfNes- cre at E16.5, the proliferative ca-
pacity of progenitors was not significantly
different (Fig. 6A,B). Our results demon-
strate that Puma deletion rescues cell
death in the Ctcf-null brain, but that the
rescued cells display reduced proliferative
capacity.
Three NPC subtypes exist in the em-
bryonic cortex: apical radial glia (apical
progenitors), basal progenitors, and outer
radial glia. Apical progenitors can be iden-
tified by their expression of SOX2 and
PAX6 transcription factors (Go¨tz et al.,
1998; Tarabykin et al., 2001; Bani-
Yaghoub et al., 2006; Shitamukai and
Matsuzaki, 2012). They undergo interki-
netic nuclear migration and divide at the
ventricular surface to either self-renew or
differentiate into basal progenitors, outer
radial glia, or cortical neurons (Shitamu-
kai et al., 2011; Shitamukai and Matsu-
zaki, 2012). Basal progenitors reside in the
subventricular zone and uniquely express
the T-box transcription factor TBR2 (En-
glund et al., 2005). They are reported to
have the potential to self-renew; however,
the majority of their divisions are neuro-
genic (Haubensak et al., 2004; Miyata et
al., 2004; Noctor et al., 2004). Outer radial
glia are similar to radial glia in that they
have a basal process and express SOX2
and PAX6; however, oRG cells are located
outside of the VZ in the outer SVZ. They
are able to divide asymmetrically, producing one oRG and one
neuron-committed cell with each division (Reillo et al., 2011;
Shitamukai et al., 2011; Wang et al., 2011a,b; Shitamukai and
Matsuzaki, 2012).We performed acute BrdU-labeling for 1 h and
coimmunostained E16.5 cortical sections with antibodies against
BrdU and TBR2 or SOX2 to examine the behavior of different
progenitor subtypes after loss of CTCF (Figs. 7, 8).
The total number of TBR2 basal progenitor cells was re-
duced in the CtcfNes-cre cortex compared to control (Fig. 7A,B).
The number of basal progenitors was restored to control levels in
the CtcfNes-cre;Puma/ cortex, and most rescued cells were still
able to enter S phase (Fig. 7A,C). Despite the correct overall
number of TBR2 cells in the CtcfNes-cre;Puma/ cortex, the
localization of basal progenitors appeared to be shifted apically
compared to control (Fig. 7A,B). This is perhaps due to an in-
ability of the rescued basal progenitors to correctly delaminate
from the ventricular surface.
Quantification of SOX2 cells indicated a dramatic reduction
in the number of apical progenitors and oRGs in the CtcfNes-cre
cortex (Fig. 8A,B). The number of SOX2 apical progenitorswas
only partially rescued in the CtcfNes-cre;Puma/ cortex, indicating
that CTCF may control the size of the apical progenitor pool
independently of apoptosis (Fig. 8A,B). Conversely, oRG
(SOX2 cells in the intermediate zone) numberswere restored to
control levels in the CtcfNes-cre;Puma/ cortex, indicating that
these cells are lost via Puma-mediated apoptotic cell death upon
deletion of Ctcf (Fig. 8A,B). The proliferative capacity of apical
progenitors (SOX2/BrdU cells in the VZ/SVZ) was severely
diminished in the CtcfNes-cre cortex compared to control, and was
not restored in theCtcfNes-cre;Puma/ cortex (Fig. 8A,C). Similarly,
BrdU incorporation in the rescuedCtcfNes-cre;Puma/oRG cells was
extremely low, indicating that they are likely arrested in the cell
cycle and fail to correctly enter S phase (Fig. 8A,C). To confirm
that these cells are oRG progenitors, we performed SOX2 and
PAX6 coimmunostaining and indeed observed a decreased num-
ber of SOX2PAX6 cells in the intermediate zone of CtcfNes-cre
embryos compared to control and CtcfNes-cre;Puma/ at E16.5
(Fig. 8D).
Ctcf loss causes premature differentiation of apical
progenitors
Incomplete restoration of the apical progenitor population in the
CtcfNes-cre;Puma/ cortex suggests that loss of CTCF leads to an
apoptosis-independent reductionof these cells (Fig. 8A,B).To iden-
tify the cause of reduced apical cell numbers, we analyzed the pro-
genitor pool composition, cell cycle exit indices, and postmitotic
projection neuron subtypes in control andCtcfNes-cre cortex at E14.
Apical progenitors begin to produce projection neurons at
approximately E11.5. At the same time, they generate neuron-
committed basal progenitors and oRGprogenitors. Since thema-
jority of basal progenitor divisions are terminal and result in the
production of two neurons, this would result in increased gener-
ation of neurons at the expense of the progenitor pool (Hauben-
sak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). The
relative abundance of TBR2 basal progenitors was significantly
increased in the E14 CtcfNes-cre cortex compared to control,
whereas the number of SOX2 apical progenitors was not af-
Figure 5. Puma deletion in the Ctcf-deficient brain fails to restore hippocampal size or hypocellularity of the cortical plate. A,
H&E staining of neonatal (P0.5) control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma/ cortex and hippocampus. Scale bars: top, 800m;
bottom, 200m. Original magnification, 25	. B, Graph depicting cortical plate cell counts as a percentage of control (n 3).
Error bars represent SEM.
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fected (Fig. 9A,B), suggesting that differentiation of apical pro-
genitors into basal progenitors is increased. Next, we measured
the proportion of cells exiting the cell cycle by labeling embryos
with BrdU for 24 h and analyzing Ki67 and BrdU cells in E14
control and CtcfNes-cre cortex. Cell cycle exit (BrdUKi67 cells/
total BrdU cells) was significantly higher in CtcfNes-cre cortex
compared to controls (Fig. 9C,D).
The cortical plate is established by projection neurons that
organize themselves in an “inside-out” manner, such that early-
born neurons populate deeper cortical layers (layer VI, then layer
V), and late-born neuronsmigrate past the early-born neurons to
populate the more superficial layers of the cortex (layer IV, then
layer II/III; Greig et al., 2013). Increased cell cycle exit and differ-
entiation at E13–E14 is predicted to result in an increased num-
ber of layer VI corticothalamic projection neurons (TBR1),
layer V subcerebral projection neurons (CTIP2), and callosal
projection neurons (SATB2). We found that the relative gener-
ation of these neuronal subtypes was increased in the CtcfNes-cre
cortex compared to control (Fig. 8E--G), confirming premature
differentiation of Ctcf-null apical progenitors, which is predicted
to result in a reduced number of this progenitor pool by late
neurogenesis.
Discussion
This study provides evidence that CTCF is required at very early
stages of telencephalon development for the maintenance and
survival of neuroprogenitor cells. We found that ablation of
CTCF leads to Puma-dependent apoptosis of NPCs using two
different conditional deletion strategies. Increased apoptosis cor-
related with p53-dependent Puma transcription, suggesting that
CTCF loss results in p53 stabilization and transcriptional activa-
tion of its downstream targets. CTCF loss might also result in a
more open chromatin environment at the Puma gene, facilitating
p53-dependent activation of transcription and elongation of
RNA polymerase II (Gomes and Espinosa, 2010a,b). Ctcf inacti-
vation in postmitotic cortical and hippocampal neurons does not
induce apoptosis (Hirayama et al., 2012), pointing to a specific
survival role for CTCF in proliferating cells. However, CTCF loss
of function may not induce apoptosis in all types of proliferating
cells in vivo, as Ctcf deletion in thymocytes was shown previously
to induce cell cycle arrest without induction of apoptosis (Heath
et al., 2008). It is possible that the outcome of CTCF deficiency
leads to either p53-dependent cell cycle arrest or apoptosis, de-
pending on varying cell-specific or temporal cues. This could be
similar to the outcomes described uponNbs1 (Nijmegen breakage
syndrome 1/Nibrin) deletion in the CNS, which leads to p53-
dependent apoptosis in the cerebellum, but causes p53-
dependent cell cycle arrest in the neocortex (Li et al., 2012).
In the present report, we demonstrate that deletion of Puma
effectively rescues apoptotic cell death observed at E16.5 in the
CtcfNes-cre brain (Fig. 4). Despite this apparent recovery at E16.5,
Figure6. Ctcf-deficient cells that are rescued fromapoptotic deathdisplay reducedproliferative capacity. Pregnant femaleswere subjected to a 1hBrdUpulse before being killed.A, BrdU (green)
immunostaining of E16.5 control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma/ cortical cryosections. The inset demonstrates fewer BrdU cells in the Ctcf Nes-cre and Ctcf Nes-cre;Puma/ IZ compared with
control. Scale bar, 50m. Original magnification, 100	. B, The number of cells in S phase was quantified by counting BrdU cells in 200-m-wide cortical images (n 3). Error bars represent
SEM.
Figure 7. Ctcf-deficiency results in PUMA-dependent apoptosis of basal progenitor cells. Pregnant femaleswere subjected to a 1 h BrdU pulse before being killed.A, TBR2 (red) and BrdU (green)
coimmunostaining of E16.5 cortical cryosections. Arrowheads indicate TBR2/BrdU cells in the IZ and VZ/SVZ. Scale bar, 50m. Original magnification, 100	. B, TBR2 cells were quantified
in 200-m-wide cortical images (n 3). C, TBR2/BrdU cells were quantified in 200-m-wide cortical images (n 3). Error bars represent SEM.
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the double mutant brain at birth appeared hypocellular and was
nearly undistinguishable histologically from the CtcfNes-cre brain
(Fig. 5). We showed that CtcfNes-cre;Puma/ apical and oRG
progenitors that cannot activate the apoptotic pathway fail to
incorporate BrdU, which might be explained by a p53-mediated
cell cycle arrest. Further investigations into the mechanism un-
derlying increased p53 levels in the Ctcf-null brain will be impor-
tant to fully elucidate the role of CTCF in progenitor cell survival.
Given that oRG cells are implicated in neocortical expansion in
humans, their reduced ability to proliferate in the double mutant
cortex might partly explain the failure to recover cortical size at
birth, andmay be relevant to microcephaly caused by CTCFmu-
tations in humans (Hansen et al., 2010; Lui et al., 2011; Reillo et
al., 2011).
A key observation is that deletion of Puma did not completely
restore the number of apical cells in the CtcfNes-cre;Puma/ cor-
Figure 8. Ctcf-deficiency results in PUMA-dependent apoptosis of apical and outer radial glia progenitors. Apical and outer radial glia progenitors that are rescued from apoptotic death fail to
proliferate. Pregnant females were subjected to a 1 h BrdU pulse before being killed. A, SOX2 (red) and BrdU (green) coimmunostaining of E16.5 cortical cryosections. The inset demonstrates fewer
SOX2 cells in the Ctcf Nes-cre IZ than control or Ctcf Nes-cre;Puma/. B, SOX2 cells were quantified in 200-m-wide cortical images (n 3). C, SOX2/BrdU cells were quantified in
200-m-wide cortical images (n 3). D, Immunodetection of SOX2 (green) and PAX6 (red) in the E16.5 cortical IZ demonstrates restoration of oRG progenitors in Ctcf Nes-cre;Puma/ cortex
compared to Ctcf Nes-cre. Arrowheads indicate SOX2/PAX6 oRG cells. Error bars represent SEM. Original magnification: A, D, 100	. Scale bars: A, 50m; D, 10m.
Figure 9. Ctcf-deficiency causes premature neurogenesis.A, Immunodetection of SOX2 (red) and TBR2 (green) in E14 control and Ctcf Nes-cre cortex.B, SOX2, TBR2, and SOX2/TBR2 cells
were quantified in 150-m-wide cortical images and expressed as a percentage of total DAPI cells (n 3). C, Pregnant femalemicewere subjected to a 24 h BrdU pulse before being killed. Ki67
(red) and BrdU (green) immunostaining was used to determine the percentage of cells exiting the cell cycle in control and Ctcf Nes-cre E14 cortex. Arrowheads indicate BrdUKi67 cells that have
exited the cell cycle. D, Cell cycle exit indices were calculated bymeasuring the ratio of BrdUKi67 cells to total BrdU cells in control and Ctcf Nes-cre cortex at E14 (n 3). E, Immunodetection
of TBR1 (red) and SATB2 (green) in E14 control and Ctcf Nes-cre cortex.F, Immunodetection of CTIP2 (green) in E14 control and Ctcf Nes-cre cortex.G, SATB2, TBR1, and CTIP2 cellswere quantified
and expressed as a percentage of DAPI cells (n 3). Error bars represent SEM. Original magnification: A, C, E, F, 100	. Scale bars: A, C, 50m; E, F, 50m.
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tex, suggesting that while a proportion of this progenitor popu-
lation undergoesPuma-dependent death in the absence of CTCF,
apical cells exhibit an independent defect. We found that Ctcf-
null apical progenitors differentiate prematurely, causing an
initial increase in the production of basal progenitors and early-
born postmitotic neurons (Fig. 9). However, the increased num-
ber of basal progenitors is later counteracted by a reduction of the
progenitor pool fromwhich they are derived, and exacerbated by
increased levels of apoptosis. Given that CTCF colocalizes with
the cohesin complex and is required for cohesin localization to
specific genomic sites to influence gene expression (Parelho et al.,
2008; Wendt et al., 2008), it is conceivable that premature neu-
rogenesis in the CtcfNes-cre cortex results from dysregulation of
CTCF target genes.
The number of basal progenitor cellsmarked by TBR2 expres-
sion was completely restored in the double mutant brain, indi-
cating that PUMA activation causes basal progenitor cell death in
the absence of CTCF. Simultaneous labeling of brain sections
with TBR2 and BrdU showed that rescued basal progenitors are
still able to proliferate, unlike rescued apical and oRG cells. De-
spite the overall equivalent number of TBR2 cells in the control
and double mutant cortex, several rescued basal progenitors did
not move basally out of the ventricular zone, perhaps due to a
defect in apical radial glia or an inability to correctly delaminate
from the apical surface of the Ctcf-deficient cortex.
In summary, we demonstrated that CTCF is required in the
early developing mouse brain for neuroprogenitor cell survival
and that its deletion induces p53- andPUMA-dependent apopto-
sis. Independent from its role in promoting cell survival, CTCF is
required for the correct balance of proliferative versus differen-
tiative divisions and maintenance of the apical progenitor pool.
Together, these functions of CTCF contribute to the normal de-
velopment of the mammalian neocortex.
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